UPDATE: Due to the high circulation of the SARS-CoV-2 Omicron variant, our antibody combination is not currently authorized for use in any U.S. Region. Please refer to the authorized Fact Sheet and FDA statement for additional details.
Learn More

Pipeline & Medicines HELPING PEOPLE WITH
SERIOUS DISEASES

Our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our pipeline is powered by end-to-end research and development capabilities, and our commitment to operational excellence and patient safety ensures we consistently produce the highest-quality medicines.

Our approved medicines

Our unique ability to apply the power of science and technology has led to the discovery and development of nine FDA approved medicines.

REVIEW OUR FDA-APPROVED MEDICINES

Industrial Operations and Product Supply

Grounded in excellence and driven to continuously improve, our industry-leading IOPS team is responsible for the production of our many medicines.

EXPLORE OUR OPERATIONS
Two female scientists looking into miscroscopes.

Investigating new medicines for serious diseases

Our pipeline of over 30 investigational medicines is comprised of primarily ‘homegrown’ therapeutics for dozens of diseases.

Explore our clinical trials

The discoveries never stop as we work to help people with serious diseases. Clinical trials allow us to carefully test and collect data about investigational products before they can be approved for use. Learn more about our clinical trials or find a relevant one near you.

FIND TRIALS

We're on call

Healthcare professionals, patients or caregivers who would like to request specific product information, report an adverse event or share feedback regarding a Regeneron product can contact our medical information team at:

844-REGN-MID (844-734-6643) or

Submit an inquiry
Back
to top